These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29150293)

  • 1. A unique and promising combination of medications for the treatment of Alzheimer's disease.
    Weinstein JD
    Med Hypotheses; 2017 Nov; 109():53-55. PubMed ID: 29150293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new direction for Alzheimer's research.
    Weinstein JD
    Neural Regen Res; 2018 Feb; 13(2):190-193. PubMed ID: 29557358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of neuronal energy crisis in Alzheimer's disease.
    de la Torre JC
    Neurodegener Dis; 2008; 5(3-4):126-32. PubMed ID: 18322369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease.
    Panza F; Solfrizzi V; Seripa D; Imbimbo BP; Lozupone M; Santamato A; Zecca C; Barulli MR; Bellomo A; Pilotto A; Daniele A; Greco A; Logroscino G
    Biomed Res Int; 2016; 2016():3245935. PubMed ID: 27429978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MGEKN; Tabet N
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002854. PubMed ID: 28418065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MG; Tabet N
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002854. PubMed ID: 28128435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of human cognitive neuroscience in drug discovery for the dementias.
    Wesnes KA; Edgar CJ
    Curr Opin Pharmacol; 2014 Feb; 14():62-73. PubMed ID: 24565014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple substrates of late-onset dementia: implications for brain protection.
    Kalaria RN; Ballard CG; Ince PG; Kenny RA; McKeith IG; Morris CM; O'Brien JT; Perry EK; Perry RH; Edwardson JA
    Novartis Found Symp; 2001; 235():49-60; discussion 60-5. PubMed ID: 11280033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nimodipine for primary degenerative, mixed and vascular dementia.
    López-Arrieta JM; Birks J
    Cochrane Database Syst Rev; 2002; (3):CD000147. PubMed ID: 12137606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical Discoveries on Multi-Target Approach to Manage Alzheimer's Disease.
    Batool A; Kamal MA; Rizvi SMD; Rashid S
    Curr Drug Metab; 2018; 19(8):704-713. PubMed ID: 29512457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.
    Fioravanti M; Flicker L
    Cochrane Database Syst Rev; 2001; 2001(4):CD003159. PubMed ID: 11687175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation and Alzheimer's disease.
    Lee YJ; Han SB; Nam SY; Oh KW; Hong JT
    Arch Pharm Res; 2010 Oct; 33(10):1539-56. PubMed ID: 21052932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease.
    Sahoo AK; Dandapat J; Dash UC; Kanhar S
    J Ethnopharmacol; 2018 Apr; 215():42-73. PubMed ID: 29248451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial association of angiotensin-converting enzyme inhibitors and statins on the occurrence of possible Alzheimer's disease after traumatic brain injury.
    Li M; Reisman J; Morris-Eppolito B; Qian SX; Kazis LE; Wolozin B; Goldstein LE; Xia W
    Alzheimers Res Ther; 2020 Mar; 12(1):33. PubMed ID: 32220235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotherapeutic strategies for the treatment of Alzheimer's disease.
    Gu X; Chen H; Gao X
    Ther Deliv; 2015 Feb; 6(2):177-95. PubMed ID: 25690086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nimodipine for primary degenerative, mixed and vascular dementia.
    López-Arrieta ; Birks J
    Cochrane Database Syst Rev; 2001; (1):CD000147. PubMed ID: 11279679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease in the zebrafish: where can we take it?
    Caramillo EM; Echevarria DJ
    Behav Pharmacol; 2017 Apr; 28(2 and 3-Spec Issue):179-186. PubMed ID: 28177980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms.
    von Bernhardi R; Eugenín J
    Antioxid Redox Signal; 2012 May; 16(9):974-1031. PubMed ID: 22122400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
    Wilcock GK; Black SE; Hendrix SB; Zavitz KH; Swabb EA; Laughlin MA;
    Lancet Neurol; 2008 Jun; 7(6):483-93. PubMed ID: 18450517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.